Healthy Extracts Inc. (OTCMKTS:HYEX) Stock Rockets 45% After New Clinical Study

Shares of Healthy Extracts Inc. (OTCMKTS:HYEX) were among the biggest gainers in the previous session.

Market Stats

On Tuesday, HYEX stock soared 47.44% to $0.0575 with more than 2K shares, compared to its average volume of 30k shares. The stock moved within a range of $0.0575 – 0.0575 after opening trading at $0.0575.

Clinical Study of UBN Relief Shows Promising Results, as Reported by Healthy Extracts

Leading innovator of clinically proven plant-based products for heart and brain health, Healthy Extracts Inc. (OTCMKTS:HYEX) has reported promising results of a prospective, randomized, double-blind, placebo-controlled clinical trial that studied its migraine headache formulation – UBN RELIEF.

Taking a single dose of UBN RELIEF for 60 days can naturally reduce or alleviate symptoms associated with migraines. It can improve cognitive function, sleep satisfaction and overall quality of life too. The results were published in World Journal of Advanced Research and Reviews.

As per government health studies, one in six Americans, is affected due to migraine and severe headaches. The former is among the top reasons for emergency room visits, and a high percentage of migraine episodes result in both temporary and long-term disability.

UBN RELIEF is based on a specialized version of a Healthy Extracts proprietary, patent-protected formulation. Ingredients are naturally sourced, and contain zero caffeine or added sugar. Healthy Extracts president, Duke Pitts stresses on the fact that the positive results of the study were achieved sans any harmful side effects.

Key Quote

Dr. Gerald M. Haase, clinical professor of surgery at the University of Colorado School of Medicine and Children’s Hospital Colorado, and one of the researchers for the trial, commented: “These strong results clearly demonstrate the ability of UBN RELIEF to alleviate symptoms associated with migraines and improve quality of life when taken on a daily basis for 60 days. Moreover, the conclusions of the study reveal that UBN RELIEF can be a natural alternative for the tens of millions of migraine sufferers. Healthcare providers and consumers can be confident this natural formulation works based on these clinical studies.”

Pete Matthews

Pete attended the University of Colorado and still calls the centennial state home. He chases trout in the summer and snowboards in the winter. He is fascinated with the markets and has a strong interest in nanocap stocks and crypto currency.